Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Slides:

Advertisements

Similar presentations

Objective assessment of gastroesophageal reflux after short esophagomyotomy for achalasia with the use of manometry and pH monitoring John M. Streitz,

Advertisements

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H

Lung cancer screening: No more excuses

Survival after resection of synchronous non–small cell lung cancer

Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection* T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.

Tumors of the esophagogastric junction

Jean Paul A. Couetil, MDa, Didier P

Improved myocardial protection in minimally invasive aortic valve surgery with the assistance of port-access technology Shubjeet Kaur, MDa, Jorge Balaguer,

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: A randomized clinical trial Michael Burt, MD, PhDa, Andrew Scott,

Rodney J. Landreneau, MDa, David J. Sugarbaker, MDb, Michael J

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer J. Buhr,

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Proposed Revision Of The Staging Classification For Esophageal Cancer

The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer Yukito Ichinose, MDa, Tokujiro.

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients Raja.

Nael Martini, MDa, Muhammad B. Zaman, MDb, Manjit S

A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results Manjit S. Bains, MDa, Alexander Stojadinovic,

Visceral Pleural Invasion Classification in Non-small Cell Lung Cancer

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer Jun-ichi Ogawa, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Subxiphoid pericardial drainage for pericardial tamponade

Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Carcinoma of the esophagus: Prognostic significance of histologic type

Low-grade fibromyxoid sarcoma arising in the mediastinum

Nael Martini: A Leader in Thoracic Surgical Oncology

Thomas W. Rice, MD The Journal of Thoracic and Cardiovascular Surgery

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma Valerie W. Rusch, MDa, Kenneth.

Superior sulcus lung tumors: Impact of local control on survival

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Postbypass effects of delayed rewarming on cerebral blood flow velocities in infants after total circulatory arrest Rosendo A. Rodriguez, MD, PhDa (by.

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Positron emission tomography predicts survival in malignant pleural mesothelioma Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,

Discussion The Journal of Thoracic and Cardiovascular Surgery

Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed Melanie P. Subramanian, MD, Varun Puri, MD, MSCI

The future of cardiac surgery training: A survival guide

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Neal S Goldstein, MD The Annals of Thoracic Surgery

Therapeutic R2 resection for pleural mesothelioma

Thomas J. Kirby, MDa (by invitation), Michael J

Raja M. Flores, MD, Bernard J

Aritoshi Hattori, MD, Kenji Suzuki, MD

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis William.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung.

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Michael J. Weyant, MD, Manjit S

Presentation transcript:

Incidence of local recurrence and second primary tumors in resected stage I lung cancer Nael Martini, MDa, Manjit S. Bains, MDa, Michael E. Burt, MD, PhDa, Maureen F. Zakowski, MDb (by invitation), Patricia McCormack, MDa, Valerie W. Rusch, MDa, Robert J. Ginsberg, MDa The Journal of Thoracic and Cardiovascular Surgery Volume 109, Issue 1, Pages 120-129 (January 1995) DOI: 10.1016/S0022-5223(95)70427-2 Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 1 Overall survival after resection of stage I non-small-cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Survival by T factor in resected stage I lung cancer. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Survival by tumor size in centimeters. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Survival by visceral pleural invasion and tumor size. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 5 Survival by histologic type. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 6 Survival by T factor in resected stage I nonsquamous cancers. The Journal of Thoracic and Cardiovascular Surgery 1995 109, 120-129DOI: (10.1016/S0022-5223(95)70427-2) Copyright © 1995 Mosby, Inc. Terms and Conditions